Akros Pharma
Metabolic-modulator therapeutics (Kaken Pharmaceutical subsidiary)
Subsidiary of Shionogi (4507) · United States
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 2 | Pyruvate dehydrogenaseSmall molecule | Heart Failure |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.